For research use only. Not for therapeutic Use.
Desmethyl Erlotinib-d4 is a high-purity deuterated compound designed for advanced pharmaceutical and biochemical research. This isotopically labeled version of Desmethyl Erlotinib is crucial for studies involving epidermal growth factor receptor (EGFR) inhibition, cancer therapy, and drug metabolism. Featuring four deuterium atoms, it ensures precise and reliable analytical results. Its advanced formulation provides enhanced stability and consistency, making it suitable for various experimental setups. Ideal for oncology research and drug development, Desmethyl Erlotinib-d4 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.
Catalog Number | S001040 |
CAS Number | 1216420-11-9 |
Molecular Formula | C21H17D4N3O4 |
Purity | ≥95% |
IUPAC Name | 2-[7-(2-methoxyethoxy)-4-(2,3,4,6-tetradeuterio-5-ethynylanilino)quinazolin-6-yl]oxyethanol |
InChI | InChI=1S/C21H21N3O4/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(27-8-7-25)20(28-10-9-26-2)13-18(17)22-14-23-21/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24)/i4D,5D,6D,11D |
InChIKey | KOQIAZNBAWFSQM-GTNXRJHWSA-N |
SMILES | [2H]C1=C(C(=C(C(=C1[2H])NC2=NC=NC3=CC(=C(C=C32)OCCO)OCCOC)[2H])C#C)[2H] |